Beruflich Dokumente
Kultur Dokumente
Hot Drinks in
India
www.datamonitor.com
Datamonitor USA Datamonitor Europe Datamonitor Middle East Datamonitor Asia Pacific
245 Fifth Avenue 119 Farringdon Road and North Africa Level 46, 2 Park Street
4th Floor London EC1R 3DA Datamonitor Sydney, NSW 2000
New York, NY 10016 United Kingdom PO Box 24893 Australia
USA Dubai, UAE
t: +44 20 7551 9000
t: +1 212 686 7400 f: +44 20 7675 7500 t: +49 69 9754 4517 t: +61 2 8705 6900
f: +1 212 686 2626 e: eurinfo@datamonitor.com f: +49 69 9754 4900 f: +61 2 8705 6901
e: usinfo@datamonitor.com e: datamonitormena@ e: apinfo@datamonitor.com
datamonitor.com
EXECUTIVE SUMMARY
Market value
The Indian hot drinks market grew by 9.6% in 2009 to reach a value of $1,962.5 million.
Market value forecast
In 2014, the Indian hot drinks market is forecast to have a value of $2,897 million, an increase of 47.6%
since 2009.
Market volume
The Indian hot drinks market grew by 6.9% in 2009 to reach a volume of 475.5 million kilograms.
Market volume forecast
In 2014, the Indian hot drinks market is forecast to have a volume of 623.8 million kilograms, an increase
of 31.2% since 2009.
Market segmentation I
Tea is the largest segment of the hot drinks market in India, accounting for 69.9% of the market's total
value.
Market segmentation II
India accounts for 11.3% of the Asia-Pacific hot drinks market value.
Market share
Tata Tea is the leading player in the Indian hot drinks market, generating a 18.4% share of the market's
volume.
Market rivalry
The Indian hot drinks market is relatively fragmented, with top three players holding 47.3% of the total
market volume.
TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET VOLUME 11
MARKET SEGMENTATION I 12
MARKET SEGMENTATION II 13
MARKET SHARE 14
Summary 15
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Tata Tea 21
Unilever 25
GlaxoSmithKline Plc 30
MARKET DISTRIBUTION 35
MARKET FORECASTS 36
MACROECONOMIC INDICATORS 38
APPENDIX 40
Methodology 40
Industry associations 41
Disclaimer 43
ABOUT DATAMONITOR 44
Premium Reports 44
Summary Reports 44
Datamonitor consulting 44
LIST OF TABLES
Table 1: India hot drinks market value: $ million, 200509 10
Table 4: India hot drinks market segmentation II: % share, by value, 2009 13
Table 19: India hot drinks market value forecast: $ million, 200914 36
Table 20: India hot drinks market volume forecast: million kilograms, 200914 37
Table 21: India size of population (million), 200509 38
LIST OF FIGURES
Figure 1: India hot drinks market value: $ million, 200509 10
Figure 4: India hot drinks market segmentation II: % share, by value, 2009 13
Figure 7: Drivers of buyer power in the hot drinks market in India, 2009 16
Figure 8: Drivers of supplier power in the hot drinks market in India, 2009 17
Figure 9: Factors influencing the likelihood of new entrants in the hot drinks market in India, 2009 18
Figure 10: Factors influencing the threat of substitutes in the hot drinks market in India, 2009 19
Figure 11: Drivers of degree of rivalry in the hot drinks market in India, 2009 20
Figure 19: India hot drinks market value forecast: $ million, 200914 36
Figure 20: India hot drinks market volume forecast: million kilograms, 200914 37
MARKET OVERVIEW
Market definition
The hot drinks market consists of the retail sales of coffee, tea and other hot drinks. The market is valued
according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used
in the creation of this report have been calculated using 2009 annual average exchange rates.
For the purpose of this report Asia-Pacific comprises Australia, China, Japan, India, Singapore, South
Korea and Taiwan.
Research highlights
The Indian hot drinks market generated total revenues of $2 billion in 2009, representing a compound
annual growth rate (CAGR) of 8.5% for the period spanning 2005-2009.
Tea sales proved the most lucrative for the Indian hot drinks market in 2009, generating total revenues of
$1.4 billion, equivalent to 69.9% of the market's overall value.
The performance of the market is forecast to decelerate, with an anticipated CAGR of 8.1% for the five-
year period 2009-2014, which is expected to lead the market to a value of $2.9 billion by the end of 2014.
Market analysis
The Indian hot drinks market grew at a strong rate during 2005-2009, reaching its peak of 9.6% in 2008-
2009. The overall market growth is expected to decelerate in the forthcoming five years, with annual rate
dropping to 7.4% in 2014.
The Indian hot drinks market generated total revenues of $2 billion in 2009, representing a compound
annual growth rate (CAGR) of 8.5% for the period spanning 2005-2009. In comparison, the Chinese and
Japanese markets grew with CAGRs of 7.5% and 1.1% respectively, over the same period, to reach
respective values of $10.3 billion and $4.4 billion in 2009.
Market consumption volumes increased with a CAGR of 6.1% between 2005 and 2009, to reach a total of
475.5 million kilograms in 2009. The market's volume is expected to rise to 623.8 million kilograms by the
end of 2014, representing a CAGR of 5.6% for the 2009-2014 period.
Tea sales proved the most lucrative for the Indian hot drinks market in 2009, generating total revenues of
$1.4 billion, equivalent to 69.9% of the market's overall value. In comparison, sales of coffee generated
revenues of $144.8 million in 2009, equating to 7.4% of the market's aggregate revenues.
The performance of the market is forecast to decelerate, with an anticipated CAGR of 8.1% for the five-
year period 2009-2014, which is expected to lead the market to a value of $2.9 billion by the end of 2014.
Comparatively, the Chinese and Japanese markets will grow with CAGRs of 6.7% and 1.2% respectively,
over the same period, to reach respective values of $14.2 billion and $4.6 billion in 2014.
MARKET VALUE
The Indian hot drinks market grew by 9.6% in 2009 to reach a value of $1,962.5 million.
The compound annual growth rate of the market in the period 200509 was 8.5%.
MARKET VOLUME
The Indian hot drinks market grew by 6.9% in 2009 to reach a volume of 475.5 million kilograms.
The compound annual growth rate of the market in the period 200509 was 6.1%.
MARKET SEGMENTATION I
Tea is the largest segment of the hot drinks market in India, accounting for 69.9% of the market's total
value.
The other hot drinks segment accounts for a further 22.7% of the market.
Table 3: India hot drinks market segmentation I:% share, by value, 2009
Category % Share
Tea 69.9%
Other hot drinks 22.7%
Coffee 7.4%
Total 100%
Figure 3: India hot drinks market segmentation I:% share, by value, 2009
MARKET SEGMENTATION II
India accounts for 11.3% of the Asia-Pacific hot drinks market value.
China accounts for a further 52% of the Asia-Pacific market.
Table 4: India hot drinks market segmentation II: % share, by value, 2009
Category % Share
China 52.0%
Japan 20.4%
India 11.3%
South Korea 5.9%
Rest of Asia-Pacific 10.4%
Total 100%
Figure 4: India hot drinks market segmentation II: % share, by value, 2009
MARKET SHARE
Tata Tea is the leading player in the Indian hot drinks market, generating a 18.4% share of the market's
volume.
Unilever accounts for a further 15.9% of the market.
Company % Share
Tata Tea 18.4%
Unilever 15.9%
GlaxoSmithKline Plc 12.9%
Others 52.7%
Total 100%
The hot drinks market will be analyzed taking manufacturers of hot drinks as players. The key buyers will
be taken as retailers of hot drinks, and growers of tea leaves, coffee beans and cocoa beans as the key
suppliers.
Summary
Figure 6: Forces driving competition in the hot drinks market in India, 2009
The Indian hot drinks market is relatively fragmented, with top three players holding 47.3% of the total
market volume.
Independent retailers form the most significant distribution channel in the Indian hot drinks market. The
buyer power is weakened due to their sheer number and the fact that major buyers in the retail business
must respond to end-consumer demand by stocking the most popular brands. Main suppliers are growers
of tea leaves, coffee beans and cocoa beans and their power is moderate. Low level of product
differentiation, coupled with low switching costs, attract new entrants to the market. However, existence of
international players, with their portfolio of strong brands constitutes considerable entry barriers.
Substitutes, in the form of other soft drinks, are not a significant threat considering the high proportion of
the population consuming hot drinks products.
Buyer power
Figure 7: Drivers of buyer power in the hot drinks market in India, 2009
In India, the main distribution channels for the hot drinks market are independent retailers, which account
for 71.6% of the total market volume. The two most popular products in terms of consumption are tea and
coffee. There are some possibilities of product differentiation within this market, i.e. in terms of flavoring
and alternate blends; however, drink producers usually offer a range of various products, often similar
within a given category. Low product differentiation and switching costs boost the buyer power to a certain
extent. The market is extending beyond urban centers into smaller towns and provincial areas.
Furthermore, retailers need to stock brands that are popular with consumers, even if they are more
expensive, reducing their power. Overall, buyer power in the Indian hot drinks market is moderate.
Supplier power
Figure 8: Drivers of supplier power in the hot drinks market in India, 2009
Major suppliers to manufacturers of hot drinks products are growers of tea leaves, coffee beans and
cocoa beans. Tea, coffee and cocoa plantations require specific climatic conditions for growth and are
typically located in Africa, South-America and Asia. Tea may also be sold from the tea garden by private
sale or at offshore auctions. The low economic status of some of the countries in these regions, combined
with the large number of independent growers and the relatively undifferentiated nature of the product,
limit the supplier power of growers. Tea and coffee prices are governed by quality, supply and demand.
Furthermore, in the supply chain, brokers often act as middle men between manufacturers and growers.
Overall, supplier power with respect to the Indian hot drinks market is considered to be moderate.
New entrants
Figure 9: Factors influencing the likelihood of new entrants in the hot drinks market in India,
2009
Players in the Indian hot drinks market try to distinguish their products to some extent by stressing the
taste, quality, and even health benefits (especially for tea). Negligible switching costs for consumers
mean that they are free to shift to new players if they offer lower priced products. Furthermore, easy
access to suppliers and distribution chains, along with little regulation, lure new players into the market.
However, new entrants could face a price war from existing players, especially when a new entrant
moves into a more concentrated segment. The brand strength of the major chains is considerable, which
may negate much of the effect of low switching costs. Large multi-national companies, who manufacture
products with exceptional brand strength and generally operate within other consumer markets, e.g.
Unilever or GlaxoSmithKline, dominate the market. It may be difficult for new entrants to compete
effectively with established players. The leading players typically operate with high economies of scale
allowed by bulk production and this may constitute a considerable entry barrier for newcomers. Moreover,
innovative products, being introduced by the already established players, reduce the opportunity for new
entrants to differentiate and establish their product. For example, Unilever's Taj Mahal, a premium tea
brand, launched 10 tea bags trial packs as well as 10s pack of flavored tea bags in May 2009. Overall,
new entrants are considered to be a moderate threat to the Indian hot drinks market.
Substitutes
Figure 10: Factors influencing the threat of substitutes in the hot drinks market in India, 2009
The most popular products within the hot drinks market include tea and coffee products. Such products
form an important part of many countries cultures, limiting the threat of substitution. Consumers may opt
to reduce their caffeine intake due to health concerns, which may influence hot drinks consumption
somewhat. In such cases, soft drinks, such as functional drinks, can be potential substitutes. However,
considering the high proportion of the population consuming hot drinks products, it is unlikely that such
substitution would substantially impact upon sales. Overall, the threat of substitutes in the Indian hot
drinks market is assessed as very weak.
Rivalry
Figure 11: Drivers of degree of rivalry in the hot drinks market in India, 2009
The Indian hot drinks market is relatively fragmented, with top three players holding 47.3% of the total
market volume. Sheer number of buyers, as well as presence of large, international incumbents,
benefiting from economy of scales, boost the rivalry within this market. The degree of competition is
strengthened by low switching costs and limited possibilities of product differentiation, giving the
advantage to the well established players who can offer lower prices. High exit costs act as an exit barrier
within the hot drinks market. Furthermore, existence entry of premium and gourmet coffee brands
increases rivalry in the market. Overall, rivalry in the Indian hot drinks market is assessed as moderate.
LEADING COMPANIES
Tata Tea
Head office: 1 Bishop Lefroy Road, Kolkata 700 020, West Bengal, IND
Telephone: 91 33 22811807
Fax: 91 33 22811199
Website: www.tatatea.com
Financial year-end: March
Ticker: 500800
Stock exchange: Bombay
Tata Tea Limited offers branded tea and coffee products. The company primarily operates in India and
also has its subsidiaries in the UK and the US. The company has significant presence in plantation
activity in India and Sri Lanka. The company has operations in more than 40 countries around the world.
It operates 27 tea estates in the states of Assam and West Bengal in eastern India, and Kerala in the
south. It is headquartered in Kolkata, India and employs around 3,000 people.
The company operates its business through 3 business segments: tea, coffee and other produce and
others.
The tea business segment is engaged in the cultivation & manufacture of black tea and instant tea, tea
buying/blending and sale of tea in bulk or value added form. The key tea brands marketed by the
company include Tata Tea, Tetley and Good Earth. The company also offers several regional tea brands
in the Indian market including Kanan Devan, Chakra Gold, Agni and Gemini. The international tea brands
marketed by the company include Vitax in Poland and Jemca in Czech Republic.
The company has plantations in North India which are located in the northern part of West Bengal and in
the State of Assam. The estates in North Bengal are located in an area known as the Dooars. The
company has seven tea estates in Upper Assam located near the town of Dibrugarh. Tata Tea's
plantations in South India include two estates in the Idukki District, Kerala. It also has a 100% export-
oriented unit (KOSHER & HACCP certified), that manufactures instant tea in Munnar, Kerala, India. The
instant tea powder is used for light density 100% Teas, Iced Tea Mixes and in the preparation of Ready to
Drink (RTD) beverages. The company also exports its instant tea powder to the US, Switzerland, Austria,
Germany, Italy, Taiwan, Singapore, Japan and Australia.
Further, the company markets Tata Tea, Tetley, Kanan Devan brands of tea products across West Asia
North African Region (including UAE, Oman, Salalah, Saudi Arabia, Qatar & Bahrain); Middle East; US
and Canada.
Tata Tea also has an interest in the Sri Lankan tea industry through Watawala Plantations Limited, Sri
Lanka, where it focuses on production and marketing of tea, rubber and palm oil.
Coffee and other produce segment is engaged in growing of coffee, pepper and other plantation crops
and conversion of coffee into value added products such as roast and ground coffee & instant coffee. The
key coffee brands marketed by the company include Eight OClock Coffee, Good Earth and Grand
(Russia). It is also the supplier of coffee blends to Barista for its entire range of offerings, and the supplier
of coffee to Starbucks in India.
Others segment is involved in sale of natural mineral water, other minor crops, curing operations of coffee
and trading of items required for coffee plantations. The key brands marketed by the segment, include
Himalayan (a premium, lifestyle, mineral water).
The companys distribution network includes 38 C&F agents and 2500 stockists in India that cater to over
1.7 million retail outlets (ORG Marg Retail Audit) in India.
In March 2009, Tata Tea introduced a new drink product called T!ON, a cold drink beverage. The new tea
and fruit-based cold beverage is available in three flavors: Mango Rush, Peach Punch and Apple Buzz.
In 2009, the companys subsidiary in the UK acquired a 51% stake along with the European Bank of
Reconstruction and Development in Suntyco Holding, Russia.
Key Metrics
Tata Tea generated revenues of $1.2 billion in the financial year (FY) ended March 2010, an increase of
19.3% over 2009. The company's net income totaled $79.9 million in FY2010, a decrease of 44.3% over
2009.
Tea business segment accounted for 75.8% of the total revenue generated by the company in FY2010.
The tea business segment recorded revenues of $897.6 million, an increase of 16.4% over 2009.
The coffee and other produce segment accounted for 23.1% of the total revenue generated by the
company in FY2010. The coffee and other produce segment recorded revenues of $273.8 million in
FY2010, an increase of 28.6% over 2009.
India, accounted for 29.4% of the total revenues in the FY2010. Revenues from India reached $347.6
million in 2010, an increase of 12.6% over 2009.
Unilever
Head office: Unilever House, 100 Victoria Embankment, London EC4Y 0DY, GBR
Telephone: 44 20 7822 5252
Fax: 44 20 7822 5951
Local office: Unilever House, B. D. Sawant Marg, Chakala, Andheri East, Mumbai,
IND
Telephone: 91 22 39830000
Fax: 91 22 28249438
Website: www.unilever.com
Financial year-end: December
Ticker: UL
Stock exchange: New York
Unilever is a global manufacturer and marketer of consumer goods in the food, personal and homecare
segments. Unilever operates under a dual structure. The group has two parent companies: Unilever NV
and Unilever plc. Unilever NV is a public limited company registered in the Netherlands, while Unilever plc
is a public limited company registered in the UK and Wales. The two parent companies, Unilever NV and
Unilever plc, along with the group companies, operate as a single economic entity: Unilever. It operates
through subsidiaries in Germany, Switzerland, France, the UK, the US, and China and has operations in
over 170 countries.
The group's primary operating segment comprises three geographic regions: Western Europe, The
Americas and Asia-Africa Central and Eastern Europe (CEE). The Americas region includes operations in
North America and Latin America. The Asia-Africa CEE region includes operations in the Middle East,
Africa, South Asia, South-East Asia, North-East Asia, Australasia and Central and Eastern Europe. The
Western Europe region includes operations in France, Germany, The UK, Belgium, Italy, Netherlands,
Spain, Denmark, Norway and Sweden.
Although Unilever's operations are managed on a geographical basis, the group manages its brands
under four product categories: savoury, dressings and spreads; ice cream and beverages; personal care;
and home care and others. These categories are Unilevers principal product areas.
The savoury, dressings and spreads segment includes products like soups, bouillons, sauces, snacks,
mayonnaise, salad dressings, olive oil, margarines and spreads, and cooking products such as liquid
margarines and some frozen foods. Unilever's major brands in this segment includes: Knorr, Hellmann's,
Becel/Flora (Healthy Heart), Rama/Blue Band (Family Goodness), Calve, Wish-Bone, Amora, and Ragu.
The ice cream and beverages segment includes sales of ice cream, tea-based beverages, weight
management products, and nutritionally enhanced staples sold in developing markets. Unilever's major
brands in ice cream are sold under the international Heart brand which includes Cornetto, Magnum, Carte
dOr and Solero, Walls, Kibon, Algida and Ola. Its portfolio also includes brands like Ben & Jerrys,
Breyers, Klondike and Popsicle. Its tea-based beverages include brands such as Lipton, Brooke Bond
and PG Tips. In addition, Unilever has weight management products such as Slim Fast, and nutritionally
enhanced products include Annapurna and AdeS/Adez brands. In 2009, the company introduced Lipton
Pyramid fruit tea bags in 38 international markets. In India, the key tea brands marketed by the company
include Lipton and Brooke Bond.
The personal care segment offers skin care and hair care products; deodorants and anti-perspirants; and
oral care products. The group's major brands in this segment include Axe/Lynx, Pond's, Rexona, Dove,
Lux, and Sunsilk (including Seda/Sedal). Other brands include Suave, Clear, Lifebuoy and Vaseline,
Signal and Close Up.
In April 2009, Unilever announced it was to acquire the personal care business of the Sara Lee
Corporation. The Sara Lee major brands include Sanex, Radox and Duschdas.
Home care and other operations include a number of products such as domestic cleaners, fabric
softeners, bleaches and laundry detergents. Unilever's global brands in home care segment include Omo,
Surf, Comfort, Radiant, Skip, Snuggle, Cif, Domestos and Sun/Sunlight.
The group's operation also includes Unilever Food solutions, which is a global food service business
providing solutions for professional chefs and caterers.
In December 2008, Unilever acquired the soap business of Cosmivoire, an Ivorian agro-industry group.
Key Metrics
Unilever generated revenues of $55.4 billion in the financial year (FY) ended December 2009, a decrease
of 1.7% over 2008. The company's net income totaled $4.7 billion in FY2009, a decrease of 33.0% over
2008.
During the FY2009, the ice cream and beverages segment recorded revenues of $10.8 billion, an
increase of 0.8% over 2008.
Asia-Africa CEE accounted for 37.4% of the total revenues in FY2009. Revenues from Asia-Africa CEE,
reached $20.7 billion in FY2009, an increase of 2.9% over 2008.
GlaxoSmithKline Plc
Head office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, GBR
Telephone: 44 20 8047 5000
Fax: 44 20 8047 7807
Local office: Dr. Annie Besant Road, Worli, Mumbai, Maharashtra, IND
Telephone: 91 22 2495 9595
Fax: 91 22 2495 9494
Website: www.gsk.com
Financial year-end: December
Ticker: GSK
Stock exchange: London Stock Exchange
The company operates through two business segments: pharmaceuticals (prescription pharmaceuticals
and vaccines) and consumer healthcare [over-the-counter (OTC) medicines, oral healthcare and
nutritional healthcare].
The pharmaceuticals segment offers products for eight main therapeutic areas: respiratory, central
nervous system (CNS), anti-virals, metabolic, vaccines, cardiovascular and urogenital, anti-bacterials, and
oncology and emesis. For respiratory therapy, GSK offers: Seretide/Advair, a bronchodilator and an anti-
inflammatory inhaler; Flixotide/Flovent and Becotide/Beclovent, inhaled steroids for the treatment of
inflammation associated with asthma and COPD (chronic obstructive pulmonary disease); Serevent, a
bronchodilator to treat asthma and COPD; Ventolin, to treat bronchospasm and Flixonase/Fionase and
Beconase, for the treatment of perennial and seasonal rhinitis. The company markets the following
products in CNS therapy area: Seroxat/Paxil and Paxil CR, for the treatment of major depressive disorder;
Wellbutrin, an anti-depressant; Imigran/Imitrex, for the treatment of migraine and cluster headache;
Lamictal, for the treatment of epilepsy and bipolar disorder; and Requip, for Parkinson's disease and
restless legs syndrome (RLS).
GSK's major products in the anti-virals area include: Combivir, Ziagen, Trizivir, Epzicom/Kivexa and
Lexiva/Telzir for HIV treatment; Zeffix, for the treatment of Hepatitis B; and Valtrex, for episodic genital
herpes. GSK offers the following products for metabolic therapy area: Avandia, an insulin-sensitizing
agent; Avandamet, an insulin resistance that decreases glucose production; Avandaryl, an insulin
resistance and pancreatic insulin production stimulant; and Bonviva/Boniva, for the treatment of
osteoporosis. The company markets about 30 vaccines across the globe. Its major vaccines include
Infanrix, a vaccine against diphtheria, tetanus and pertussis; Infanrix penta/Pediarix, for protection against
hepatitis B and polio; Infanrix hexa, for the protection against Haemophilus influenza Type B; Boostrix, for
the protection against pertussis; Fluviral, a seasonal flu vaccine; Priorix, a measles, mumps and rubella
vaccine; Typherix, a vaccine for typhoid fever; Varilrix, a vaccine against varicella or chicken pox; Priorix-
Tetra, for the prevention of measles, mumps, rubella and varicella (MMRV); and Mencevax, to prevent
meningitis and Rotarix, for pediatric immunization. GSK's hepatitis vaccines include Havrix for protection
against hepatitis A; Engerix-B for protection against hepatitis B; Twinrix, combined hepatitis A and B
vaccine; FENDrix, for the prevention of Hepatitis B in patients with renal insufficiency including high-risk
groups such as pre-hemodialysis and hemodialysis patients.
In the cardiovascular and urogenital therapy area, GSK offers Coreg, for treating patients with mild,
moderate and severe heart failure, heart attack or hypertension; Levitra, for male erectile dysfunction;
Avodart, for benign prostatic hyperplasia; Arixtra, for the prophylaxis of deep vein thrombosis; Fraxiparine,
for prophylaxis of thromboembolic disorders; and Integrilin, for the prevention of early myocardial
infarction. In the anti-bacterials and anti-malarials therapy area, the company markets Augmentin, for
respiratory tract infections; Augmentin ES-600, to treat children with recurrent or persistent middle ear
infections; Augmentin XR, for pneumonia or acute bacterial sinusitis; Ceftin/Zinnat, an oral antibiotic;
Malarone, an oral anti-malarial. GSK offers the following products for oncology and emesis therapy:
Zofran, to prevent nausea and vomiting associated with chemotherapy and radiotherapy for cancer;
Hycamtin, treatment for ovarian, cervical and small cell lung cancer; Bexxar, for patients with CD20
follicular, non-Hodgkin's lymphoma; and Arranon (nelarabine), for patients with T-cell acute lymphoblastic
leukemia and T-cell lymphoblastic lymphoma. GSK also markets Betnovate and Cutivate, anti-
inflammatory steroid products; Relafen, a non steroidal anti-inflammatory drug and Zantac, for the
treatment of peptic ulcer disease, and gastric acid related disorders.
GSK's consumer healthcare segment markets OTC medicines, oral healthcare and nutritional healthcare
products. The companys principal OTC medicines include Panadol, a paracetamol/acetaminophen
analgesic; smoking control products, including Nicorette, NicoDerm, NiQuitin CQ and Nicabate;Tums, a
calcium-based antacid; Citrucel, a therapeutic bulk fiber laxative; Contac, for the treatment of colds; and
Abtei, vitamins, minerals and herbal supplements; Abreva, for the treatment of cold sores; and
FiberChoice, daily fiber supplements.
GSK offers a range of oral care products such as toothpastes and mouthwashes under the Aquafresh,
Odol, Sensodyne and Macleans brand names; and toothbrushes under the Aquafresh and Dr Best
brands. In addition, denture care products are available principally under the Polident, Poligrip and
Corega brand names.
Under the nutritional healthcare products, the company offers Lucozade, energy and sports drinks;
Ribena, a blackcurrant juice-based drink, and Horlicks milk-based malted food and chocolate drinks.
GSK announces the formation of a new standalone unit specializing in the development and
commercialization of medicines for rare diseases. In July 2009, GSK acquired Stiefel Laboratories, an
independent dermatology company.
In India, GSK operates through its subsidiary GlaxoSmithKline Consumer Healthcare Limited.
Key Metrics
GSK generated revenues of $44.2 billion in the financial year (FY) ended December 2009, an increase of
16.5% as compared to previous year. The companys net income totaled $8.6 billion in FY2009, an
increase of 20.2% over 2008.
The consumer healthcare segment accounted for 16.4% of the total revenue generated by the company
in FY2009. The consumer healthcare segment recorded revenues of $7.3 billion in FY2009, an increase
of 17.2% as compared to 2008.
Nutritional healthcare sub-segment accounted for 18.3% of the total revenue generated by the consumer
healthcare segment in FY2009. Nutritional healthcare sub-segment recorded revenues of $1.3 billion in
FY2009, an increase of 6.9% over 2008.
The rest of the world (excluding the US and the UK) accounted for 57.5% of the total revenues in FY2009.
Revenues from the rest of the world reached $25.4 billion in 2009, an increase of 25.8% over 2008.
MARKET DISTRIBUTION
Independent Retailers form the leading distribution channel in the Indian hot drinks market, accounting for
a 80.7% share of the total market's volume.
Specialist Retailers accounts for a further 9.1% of the market.
Table 18: India hot drinks market distribution: % share, by volume, 2009
Channel % Share
Independent Retailers 80.7%
Specialist Retailers 9.1%
Convenience Stores 6.7%
Others 3.5%
Total 100%
Figure 18: India hot drinks market distribution: % share, by volume, 2009
MARKET FORECASTS
Market value forecast
In 2014, the Indian hot drinks market is forecast to have a value of $2,897 million, an increase of 47.6%
since 2009.
The compound annual growth rate of the market in the period 200914 is predicted to be 8.1%.
Table 19: India hot drinks market value forecast: $ million, 200914
Figure 19: India hot drinks market value forecast: $ million, 200914
The compound annual growth rate of the market in the period 200914 is predicted to be 5.6%.
Table 20: India hot drinks market volume forecast: million kilograms, 200914
Figure 20: India hot drinks market volume forecast: million kilograms, 200914
MACROECONOMIC INDICATORS
APPENDIX
Methodology
Datamonitor Industry Profiles draw on extensive primary and secondary research, all aggregated,
analyzed, cross-checked and presented in a consistent and accessible style.
Review of in-house databases Created using 250,000+ industry interviews and consumer surveys
and supported by analysis from industry experts using highly complex modeling & forecasting tools,
Datamonitors in-house databases provide the foundation for all related industry profiles
Definitions Market definitions are standardized to allow comparison from country to country. The
parameters of each definition are carefully reviewed at the start of the research process to ensure they
match the requirements of both the market and our clients
Extensive secondary research activities ensure we are always fully up-to-date with the latest
industry events and trends
Modeling & forecasting tools Datamonitor has developed powerful tools that allow quantitative
and qualitative data to be combined with related macroeconomic and demographic drivers to create
market models and forecasts, which can then be refined according to specific competitive, regulatory
and demand-related factors
Continuous quality control ensures that our processes and profiles remain focused, accurate and
up-to-date
Industry associations
Tea Board India
14, B.T.M Sarani, P.O. Box 2172 Kolkata 700 001 India
Tel.: 91 33 2235 1411
Fax: 91 33 2221 5715
www.teaap2.indiateaportal.com
Industry profiles
Disclaimer
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form
by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior
permission of the publisher, Datamonitor plc.
The facts of this report are believed to be correct at the time of publication but cannot be guaranteed.
Please note that the findings, conclusions and recommendations that Datamonitor delivers will be
based on information gathered in good faith from both primary and secondary sources, whose
accuracy we are not always in a position to guarantee. As such Datamonitor can accept no liability
whatever for actions taken based on any information that may subsequently prove to be incorrect.
ABOUT DATAMONITOR
The Datamonitor Group is a world-leading provider of premium global business information, delivering
independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities,
Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and
Telecoms industries.
Combining our industry knowledge and experience, we assist over 6,000 of the worlds leading
companies in making better strategic and operational decisions.
Delivered online via our user-friendly web platforms, our market intelligence products and services
ensure that you will achieve your desired commercial goals by giving you the insight you need to best
respond to your competitive environment.
Premium Reports
Datamonitor's premium reports are based on primary research with industry panels and consumers.
We gather information on market segmentation, market growth and pricing, competitors and products.
Our experts then interpret this data to produce detailed forecasts and actionable recommendations,
helping you create new business opportunities and ideas.
Summary Reports
Our series of company, industry and country profiles complements our premium products, providing
top-level information on 30,000 companies, 3,000 industries and 100 countries. While they do not
contain the highly detailed breakdowns found in premium reports, profiles give you the most important
qualitative and quantitative summary information you need - including predictions and forecasts.
Datamonitor consulting
We hope that the data and analysis in this profile will help you make informed and imaginative business
decisions. If you have further requirements, Datamonitors consulting team may be able to help you. For
more information about Datamonitors consulting capabilities, please contact us directly at
consulting@datamonitor.com.